https://www.idival.org/wp-content/uploads/2022/05/cab-presentacion.jpg

Progress in the treatment of bladder cancer

12 de August de 2019

Cancer represents a major health problem. It is estimated that, in 2019, almost 280,000 people will be diagnosed with this disease in our country. These figures are higher than in previous years. The most common tumors in Spain are those of the colon, prostate, breast, lung and urinary bladder. As the number of new diagnoses […]

Read more →

Two new cases of lymphoma B lymphoplasmacytic IgA with mutation of MYD88L265P

7 de August de 2019

Recently, the description of two cases of IgA lymphoplasmacytic lymphoma B with MYD88L265P mutation has been published in the journal HISTOPATHOLOGY (FI 3,294, JCR). In this work, in which medical researchers from the IDIVAL Emerging Group of Translational Hematopathology and doctors from the Pathology and Hematology Department of the HUMV have participated, two extremely unusual […]

Read more →

Decreased levels of TNF-alpha in women treated with CPAP

6 de August de 2019

Researchers of the SPANISH SLEEP GROUP belonging to IDIVAL and who carry out their clinical and research activity in the Sleep and Ventilation Unit of our hospital have just published a new paper belonging to the cohort of the SAHS study and women. This multicenter study, which has been funded by the Carlos III Health […]

Read more →

The moment of implant-removal influences late acute periprosthetic joint infection

5 de August de 2019

Currently the same therapeutic management is recommended in all acute infections of joint prostheses, both in late acute infection (patient with normal function of the prosthesis after 3 months of implantation and with onset of symptoms of

Read more →

The added value of headache care units

31 de July de 2019

Headache is the most frequent neurological reason for medical consultation at all levels of care. In our country there are few Specialized Units in Headache; The majority of patients sent by headache from Primary Care are treated in general neurology consultations. There are very few data in the literature that have analyzed whether medical care […]

Read more →

The Valdecilla Digestive team with impact on prestigious journals

30 de July de 2019

Liver disease due to fat deposition is an emerging entity in liver pathology. The most frequent causes are alcohol consumption and / or obesity / metabolic syndrome among others (drug toxicity, autoimmune diseases etc). Dr. Cabezas with the support of Dr. Crespo, Head of the Digestive System Service and thanks to the support of the […]

Read more →

Rumination in cancer patients increases symptoms of anxiety and depression

Cancer is an important source of stress for those who suffer from it, generating in many cases symptoms of anxiety or depression, what we generically know as emotional distress or psychological distress. Detecting those patients who have a higher risk of developing emotional distress, in order to be able to perform the appropriate psychological interventions, […]

Read more →

New prognostic marker in bacterial infections

26 de July de 2019

Researchers from the Group of Epidemiology and Pathogenic and Molecular Mechanisms of Infectious Diseases and Clinical Microbiology of IDIVAL have participated in a study where the lethality of Pseudomonas aeruginosa was evaluated in bloodstream infections using an animal model. P. aeruginosa bacteria is an important cause of serious hospital infections, especially in immunocompromised patients or […]

Read more →

Nursing interventions that improve the quality of life

In 2018, the World Health Organization (WHO) estimated that 71% of deaths in the world were due to chronic diseases, and this situation was expected to worsen. In this context, the IDIVAL Nursing Group led by Professor Carmen Sarabia, a nurse from the University Nursing School of the University of Cantabria, has recently published a […]

Read more →

New therapeutic alternatives for patients with myeloma

Plitidepsin (Aplidine) is a compound originally isolated from a marine tunicate (Aplidium Albicans) that demonstrated activity against Multiple Myeloma (MM) in preclinical studies conducted in our country by Dr. Enrique Ocio in collaboration with the Dana Farber Cancer Institute (Boston, MA). Aplidine binds to a protein that is overexpressed in MM, eEF1A2 (eukaryotic translation elongation […]

Read more →